Alexion AstraZeneca Rare Disease Urges Food and Drug Administration to Advance AI Use in Rare Disease Clinical Trials
2026-07-03
PubComNonGov2026-07-03
Carter Struck
WASHINGTON, July 3 -- Alexion AstraZeneca Rare Disease, Boston, Massachusetts, offered extensive input to the Food and Drug Administration regarding the agency's AI-Enabled Optimization of Early-Phase . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, July 3 -- Alexion AstraZeneca Rare Disease, Boston, Massachusetts, offered extensive input to the Food and Drug Administration regarding the agency's AI-Enabled Optimization of Early-Phase . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026